Josa Hanzlik: The Impact of Double Red Cell Donation
Josa Hanzlik, Director Material Compliance and Product Sustainability at Haemonetics, shared a post on LinkedIn:
“Another double red cell donation.
This one felt particularly close to home, literally.
About a mile from where I live, near Swarthmore College, I rolled up my sleeve once again for the American Red Cross. And sitting beside me was a familiar sight: an MCS plus apheresis system.
But the machine isn’t really the story.
The reason for sitting in that chair is.
With a Power Red donation, an automated process collects two units of red blood cells while returning plasma and platelets to the donor. Red blood cells are the most commonly transfused blood component and are used for patients experiencing trauma or severe blood loss, undergoing surgery, and living with conditions such as sickle cell disease.
That makes the time in this chair feel very small compared with what those red cells may mean to someone else.
And honestly, that’s why I keep coming back.
It’s easy to think that making a difference has to involve something big. Sometimes it doesn’t.
Sometimes it’s finding a blood drive a mile from home.
Sometimes it’s giving a little bit of your time.
Sometimes it’s sitting still while a machine does its work, knowing that somewhere down the line, another person may need exactly what you can give.
Working around medical technology gives me one perspective on healthcare. Being the person connected to that technology gives me another.
The equipment matters. The systems matter. The people who make all of it possible matter. But ultimately, there is a patient at the other end of all of it.
That’s something worth remembering.
And that’s why, when I’m eligible, I keep coming back.
If you’re eligible to donate, consider rolling up your sleeve too.”
Stay updated with Hemostasis Today.
-
Oct 31, 2026, 12:21Niksa Bagheri: Key Shear Regimes and Physics Selection for Continuum Thrombosis Modeling
-
Oct 31, 2026, 12:14Ghaith Abu-Zeinah: International MPN Congress Honors the Life and Legacy of MPN Pioneer Dr. Richard T. Silver
-
Oct 31, 2026, 12:11Thierry Burnouf: Taipei Medical University and University of Lille Highlight Platelet Biotherapies in SfN Neuronline
-
Oct 31, 2026, 12:07Eamon Faulkner: How Oxygen Shapes Platelet–Endothelial Interactions
-
Oct 31, 2026, 12:01Abdul Mannan: IVIG in ITP – When a Temporary Response Is a Success
-
Oct 31, 2026, 11:52Breaking the Silence Around Bleeding Disorders in Women – National Bleeding Disorders Foundation
-
Oct 31, 2026, 11:21Jim Meliezer: Aspirin May Help Prevent Recurrent Preterm Birth
-
Oct 31, 2026, 11:10Elly De Bruyn: QbD Group Quiz Supports the World Federation of Hemophilia
-
Oct 31, 2026, 11:04Abhivandan Nagia: The Expanding Clinical Pipeline in Hemophilia A